{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:41:43Z","timestamp":1791081703291,"version":"4.1.0"},"reference-count":79,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Russian Foundation of Basic Research","award":["20-04-60029"],"award-info":[{"award-number":["20-04-60029"]}]},{"name":"ANRS","award":["20-04-60029"],"award-info":[{"award-number":["20-04-60029"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Pulmonary fibrosis is a common and threatening post-COVID-19 complication with poorly resolved molecular mechanisms and no established treatment. The plasminogen activator system, including urokinase (uPA) and urokinase receptor (uPAR), is involved in the pathogenesis of COVID-19 and contributes to the development of lung injury and post-COVID-19 pulmonary fibrosis, although their cellular and molecular underpinnings still remain obscure. The aim of the current study was to assess the role of uPA and uPAR in the pathogenesis of pulmonary fibrosis. We analyzed uPA and uPAR expression in human lung tissues from COVID-19 patients with pulmonary fibrosis using single-cell RNA-seq and immunohistochemistry. We modeled lung fibrosis in Plau-\/- and Plaur-\/- mice upon bleomycin instillation and explored the effect of uPAR downregulation in A549 and BEAS-2B lung epithelial cells. We found that uPAR expression drastically decreased in the epithelial airway basal cells and monocyte\/macrophage cells, whereas uPA accumulation significantly increased in tissue samples of COVID-19 patients. Lung injury and fibrosis in Plaur-\/- vs. WT mice upon bleomycin instillation revealed that uPAR deficiency resulted in pro-fibrogenic uPA accumulation, IL-6 and ACE2 upregulation in lung tissues and was associated with severe fibrosis, weight loss and poor survival. uPAR downregulation in A549 and BEAS-2B was linked to an increased N-cadherin expression, indicating the onset of epithelial\u2013mesenchymal transition and potentially contributing to pulmonary fibrosis. Here for the first time, we demonstrate that plasminogen treatment reversed lung fibrosis in Plaur-\/- mice: the intravenous injection of 1 mg of plasminogen on the 21st day of bleomycin-induced fibrosis resulted in a more than a two-fold decrease in the area of lung fibrosis as compared to non-treated mice as evaluated by the 42nd day. The expression and function of the plasminogen activator system are dysregulated upon COVID-19 infection, leading to excessive pulmonary fibrosis and worsening the prognosis. The potential of plasminogen as a life-saving treatment for non-resolving post-COVID-19 pulmonary fibrosis warrants further investigation.<\/jats:p>","DOI":"10.3390\/ijms24021382","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T02:06:03Z","timestamp":1673402763000},"page":"1382","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Urokinase System in Pathogenesis of Pulmonary Fibrosis: A Hidden Threat of COVID-19"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7162-074X","authenticated-orcid":false,"given":"Anna A.","family":"Shmakova","sequence":"first","affiliation":[{"name":"Institute of Experimental Cardiology, National Medical Research Centre of Cardiology Named after Academician E.I. Chazov, 121552 Moscow, Russia"},{"name":"Faculty of Medicine, Lomonosov Moscow State University, 119192 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5039-7152","authenticated-orcid":false,"given":"Vladimir S.","family":"Popov","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Lomonosov Moscow State University, 119192 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9931-1153","authenticated-orcid":false,"given":"Iliya P.","family":"Romanov","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Lomonosov Moscow State University, 119192 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1833-5840","authenticated-orcid":false,"given":"Nikita R.","family":"Khabibullin","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Lomonosov Moscow State University, 119192 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0570-1880","authenticated-orcid":false,"given":"Nailya R.","family":"Sabitova","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Lomonosov Moscow State University, 119192 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6830-149X","authenticated-orcid":false,"given":"Anna A.","family":"Karpukhina","sequence":"additional","affiliation":[{"name":"Koltzov Institute of Developmental Biology, 117334 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4010-6283","authenticated-orcid":false,"given":"Yana A.","family":"Kozhevnikova","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Lomonosov Moscow State University, 119192 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella V.","family":"Kurilina","sequence":"additional","affiliation":[{"name":"Institute of Experimental Cardiology, National Medical Research Centre of Cardiology Named after Academician E.I. Chazov, 121552 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoya I.","family":"Tsokolaeva","sequence":"additional","affiliation":[{"name":"Institute of Experimental Cardiology, National Medical Research Centre of Cardiology Named after Academician E.I. Chazov, 121552 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polina S.","family":"Klimovich","sequence":"additional","affiliation":[{"name":"Institute of Experimental Cardiology, National Medical Research Centre of Cardiology Named after Academician E.I. Chazov, 121552 Moscow, Russia"},{"name":"Faculty of Medicine, Lomonosov Moscow State University, 119192 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7166-7406","authenticated-orcid":false,"given":"Kseniya A.","family":"Rubina","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Lomonosov Moscow State University, 119192 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yegor S.","family":"Vassetzky","sequence":"additional","affiliation":[{"name":"Koltzov Institute of Developmental Biology, 117334 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3927-9286","authenticated-orcid":false,"given":"Ekaterina V.","family":"Semina","sequence":"additional","affiliation":[{"name":"Institute of Experimental Cardiology, National Medical Research Centre of Cardiology Named after Academician E.I. Chazov, 121552 Moscow, Russia"},{"name":"Faculty of Medicine, Lomonosov Moscow State University, 119192 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"key":"ref_1","unstructured":"(2022, April 24). WHO Director-General\u2019s Opening Remarks at the Media Briefing on COVID-19\u201418 March 2020. Available online: https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---18-march-2020."},{"key":"ref_2","unstructured":"(2022, April 24). Weekly Epidemiological Update on COVID-19\u201420 April 2022. Available online: https:\/\/www.who.int\/publications\/m\/item\/weekly-epidemiological-update-on-covid-19---20-april-2022."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"11548","DOI":"10.1038\/s41598-020-68509-x","article-title":"CT Features of COVID-19 Patients with Two Consecutive Negative RT-PCR Tests after Treatment","volume":"10","author":"Fu","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"6808","DOI":"10.1007\/s00330-020-07033-y","article-title":"Chest CT Score in COVID-19 Patients: Correlation with Disease Severity and Short-Term Prognosis","volume":"30","author":"Francone","year":"2020","journal-title":"Eur. Radiol."},{"key":"ref_5","first-page":"2557","article-title":"Pulmonary Fibrosis in the Aftermath of the COVID-19 Era (Review)","volume":"20","author":"Vasarmidi","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1148\/radiol.220019","article-title":"Chest CT\u2013Based Assessment of 1-Year Outcomes after Moderate COVID-19 Pneumonia","volume":"305","author":"Bocchino","year":"2022","journal-title":"Radiology"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Bazdyrev, E., Rusina, P., Panova, M., Novikov, F., Grishagin, I., and Nebolsin, V. (2021). Lung Fibrosis after COVID-19: Treatment Prospects. Pharmaceuticals, 14.","DOI":"10.3390\/ph14080807"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1152\/ajpcell.00375.2021","article-title":"Long-Term Complications of COVID-19","volume":"322","author":"Desai","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijtb.2020.11.003","article-title":"Post Covid 19 Pulmonary Fibrosis. Is It Real Threat?","volume":"68","author":"Rai","year":"2021","journal-title":"Indian J. Tuberc."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1182\/bloodadvances.2021004816","article-title":"Altered Fibrin Clot Structure and Dysregulated Fibrinolysis Contribute to Thrombosis Risk in Severe COVID-19","volume":"6","author":"Wygrecka","year":"2022","journal-title":"Blood Adv."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Baratella, E., Ruaro, B., Marrocchio, C., Starvaggi, N., Salton, F., Giudici, F., Quaia, E., Confalonieri, M., and Cova, M.A. (2021). Interstitial Lung Disease at High Resolution CT after SARS-CoV-2-Related Acute Respiratory Distress Syndrome According to Pulmonary Segmental Anatomy. J. Clin. Med., 10.","DOI":"10.3390\/jcm10173985"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Salton, F., Confalonieri, P., Campisciano, G., Cifaldi, R., Rizzardi, C., Generali, D., Pozzan, R., Tavano, S., Bozzi, C., and Lapadula, G. (2022). Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS. J. Clin. Med., 11.","DOI":"10.3390\/jcm11112951"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1152\/physrev.00013.2020","article-title":"Elevated Plasmin(Ogen) as a Common Risk Factor for COVID-19 Susceptibility","volume":"100","author":"Ji","year":"2020","journal-title":"Physiol. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"198845","DOI":"10.1016\/j.virusres.2022.198845","article-title":"Insight towards the Effect of the Multi Basic Cleavage Site of SARS-CoV-2 Spike Protein on Cellular Proteases","volume":"318","author":"Shokeen","year":"2022","journal-title":"Virus Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"L967","DOI":"10.1152\/ajplung.90349.2008","article-title":"The Fibrinolytic System and the Regulation of Lung Epithelial Cell Proteolysis, Signaling, and Cellular Viability","volume":"295","author":"Shetty","year":"2008","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"41770","DOI":"10.1038\/srep41770","article-title":"The Fibrogenic Actions of Lung Fibroblast-Derived Urokinase: A Potential Drug Target in IPF","volume":"7","author":"Schuliga","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1513\/pats.201201-006AW","article-title":"Coagulation Cascade Proteinases in Lung Injury and Fibrosis","volume":"9","author":"Chambers","year":"2012","journal-title":"Proc. Am. Thorac. Soc."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"982","DOI":"10.15252\/embr.201541681","article-title":"Urokinase Links Plasminogen Activation and Cell Adhesion by Cleavage of the RGD Motif in Vitronectin","volume":"17","author":"Madsen","year":"2016","journal-title":"EMBO Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrm2821","article-title":"Regulation of Cell Signalling by UPAR","volume":"11","author":"Smith","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrm977","article-title":"UPAR: A Versatile Signalling Orchestrator","volume":"3","author":"Blasi","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1093\/emboj\/19.17.4817","article-title":"Urokinase-Type Plasminogen Activator and Its Receptor Synergize to Promote Pathogenic Proteolysis","volume":"19","author":"Zhou","year":"2000","journal-title":"EMBO J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"12752","DOI":"10.1016\/S0021-9258(18)98963-5","article-title":"Plasminogen Activation by Receptor-Bound Urokinase. A Kinetic Study with Both Cell-Associated and Isolated Receptor","volume":"266","author":"Ellis","year":"1991","journal-title":"J. Biol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1073\/pnas.0236849100","article-title":"Potent Antitumor Activity of a Urokinase-Activated Engineered Anthrax Toxin","volume":"100","author":"Liu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1432-1033.1997.00316.x","article-title":"Kinetics of Reciprocal Pro-Urokinase\/Plasminogen Activation-Stimulation by a Template Formed by the Urokinase Receptor Bound to Poly(D-Lysine)","volume":"245","author":"Petersen","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1182\/blood-2006-02-001073","article-title":"Initiation of Plasminogen Activation on the Surface of Monocytes Expressing the Type II Transmembrane Serine Protease Matriptase","volume":"108","author":"Kilpatrick","year":"2006","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Rubina, K., Shmakova, A., Shabanov, A., Andreev, Y., Borovkova, N., Kulabukhov, V., Evseev, A., Popugaev, K., Petrikov, S., and Semina, E. (2022). Novel Prognostic Determinants of COVID-19-Related Mortality: A Pilot Study on Severely-Ill Patients in Russia. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0264072"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41419-021-04070-3","article-title":"Low Level of Plasminogen Increases Risk for Mortality in COVID-19 Patients","volume":"12","author":"Pacifici","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13054-020-02897-4","article-title":"Soluble Urokinase Plasminogen Activator Receptor (SuPAR) as an Early Predictor of Severe Respiratory Failure in Patients with COVID-19 Pneumonia","volume":"24","author":"Rovina","year":"2020","journal-title":"Crit. Care"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Napolitano, F., Di Spigna, G., Vargas, M., Iacovazzo, C., Pinchera, B., Spalletti Cernia, D., Ricciardone, M., Covelli, B., Servillo, G., and Gentile, I. (2021). Soluble Urokinase Receptor as a Promising Marker for Early Prediction of Outcome in COVID-19 Hospitalized Patients. J. Clin. Med., 10.","DOI":"10.3390\/jcm10214914"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1186\/s13054-020-03336-0","article-title":"Plasma Levels of the Active Form of SuPAR Are Associated with COVID-19 Severity","volume":"24","author":"Huang","year":"2020","journal-title":"Crit. Care"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijid.2021.04.026","article-title":"Admission Levels of Soluble Urokinase Plasminogen Activator Receptor (SuPAR) Are Associated with the Development of Severe Complications in Hospitalised COVID-19 Patients: A Prospective Cohort Study","volume":"107","author":"Oulhaj","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/emermed-2020-210380","article-title":"Predicting Outcomes of COVID-19 from Admission Biomarkers: A Prospective UK Cohort Study","volume":"38","author":"Arnold","year":"2021","journal-title":"Emerg. Med. J."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Nekrasova, L.A., Shmakova, A.A., Samokhodskaya, L.M., Kirillova, K.I., Stoyanova, S.S., Mershina, E.A., Nazarova, G.B., Rubina, K.A., Semina, E.V., and Kamalov, A.A. (2022). The Association of PLAUR Genotype and Soluble SuPAR Serum Level with COVID-19-Related Lung Damage Severity. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232416210"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"eabe4282","DOI":"10.1126\/scitranslmed.abe4282","article-title":"Lung Transplantation for Patients with Severe COVID-19","volume":"12","author":"Bharat","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"eaba1972","DOI":"10.1126\/sciadv.aba1972","article-title":"Single-Cell RNA Sequencing Reveals Profibrotic Roles of Distinct Epithelial and Mesenchymal Lineages in Pulmonary Fibrosis","volume":"6","author":"Habermann","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1016\/j.cell.2021.11.033","article-title":"SARS-CoV-2 Infection Triggers Profibrotic Macrophage Responses and Lung Fibrosis","volume":"184","author":"Wendisch","year":"2021","journal-title":"Cell"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1134\/S0006297919090013","article-title":"The Role of Plasminogen Activator System in the Pathogenesis of Epilepsy","volume":"84","author":"Shmakova","year":"2019","journal-title":"Biochemistry (Moscow)"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.3899\/jrheum.200547","article-title":"Angiotensin-Converting Enzyme 2, a SARS-CoV-2 Receptor, Is Upregulated by Interleukin 6 through STAT3 Signaling in Synovial Tissues","volume":"47","author":"Mokuda","year":"2020","journal-title":"J. Rheumatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"13180","DOI":"10.1073\/pnas.0605669103","article-title":"Alveolar Epithelial Cell Mesenchymal Transition Develops in Vivo during Pulmonary Fibrosis and Is Regulated by the Extracellular Matrix","volume":"103","author":"Kim","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Abaurrea, A., Araujo, A.M., and Caffarel, M.M. (2021). The Role of the IL-6 Cytokine Family in Epithelial\u2013Mesenchymal Plasticity in Cancer Progression. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22158334"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"AB76","DOI":"10.1016\/j.jaci.2016.12.294","article-title":"Inhibition of IL-6 Release in Vitro by In Vivo Administration of an IKK Inhibitor in Mice with Lung Fibrosis Induced by Poly I:C","volume":"139","author":"Belanger","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"6268","DOI":"10.1002\/jcp.29555","article-title":"Downregulation of UPAR Promotes Urokinase Translocation into the Nucleus and Epithelial to Mesenchymal Transition in Neuroblastoma","volume":"235","author":"Semina","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/jth.15327","article-title":"Biomarkers of Coagulation, Endothelial Function, and Fibrinolysis in Critically Ill Patients with COVID-19: A Single-Center Prospective Longitudinal Study","volume":"19","author":"Juneja","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.thromres.2021.02.010","article-title":"Incidence and Impact of Disseminated Intravascular Coagulation in COVID-19 a Systematic Review and Meta-Analysis","volume":"201","author":"Zhou","year":"2021","journal-title":"Thromb. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/159779a0","article-title":"Fibrinolytic Activity of Normal Urine","volume":"159","author":"Macfarlane","year":"1947","journal-title":"Nature"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/S0021-9258(18)94159-1","article-title":"Plasminogen Activation Initiated by Single-Chain Urokinase-Type Plasminogen Activator. Potentiation by U937 Monocytes","volume":"264","author":"Ellis","year":"1989","journal-title":"J. Biol. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.2174\/138161211796718215","article-title":"The Urokinase Receptor Interactome","volume":"17","author":"Eden","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/s41467-022-29344-y","article-title":"Crystal Structure and Cellular Functions of UPAR Dimer","volume":"13","author":"Yu","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ajpath.2014.08.027","article-title":"Role of the Urokinase-Fibrinolytic System in Epithelial\u2013Mesenchymal Transition during Lung Injury","volume":"185","author":"Marudamuthu","year":"2015","journal-title":"Am. J. Pathol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"FitzGerald, E.S., and Jamieson, A.M. (2020). Unique Transcriptional Changes in Coagulation Cascade Genes in SARS-CoV-2-Infected Lung Epithelial Cells: A Potential Factor in COVID-19 Coagulopathies. bioRxiv, 182972.","DOI":"10.1101\/2020.07.06.182972"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e64330","DOI":"10.7554\/eLife.64330","article-title":"SARS-CoV-2 Suppresses Anticoagulant and Fibrinolytic Gene Expression in the Lung","volume":"10","author":"Mast","year":"2021","journal-title":"eLife"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Hou, Y., Ding, Y., Nie, H., and Ji, H.-L. (2021). Fibrinolysis Influences SARS-CoV-2 Infection in Ciliated Cells. bioRxiv, 425801.","DOI":"10.1101\/2021.01.07.425801"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"9129","DOI":"10.1016\/S0021-9258(19)50398-2","article-title":"Internalization of the Urokinase-Plasminogen Activator Inhibitor Type-1 Complex Is Mediated by the Urokinase Receptor","volume":"267","author":"Olson","year":"1992","journal-title":"J. Biol. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e3730","DOI":"10.1371\/journal.pone.0003730","article-title":"Clathrin and LRP-1-Independent Constitutive Endocytosis and Recycling of UPAR","volume":"3","author":"Cortese","year":"2008","journal-title":"PLoS ONE"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.bbamcr.2014.11.025","article-title":"Urokinase Type Plasminogen Activator Mediates Interleukin-17-Induced Peripheral Blood Mesenchymal Stem Cell Motility and Transendothelial Migration","volume":"1853","author":"Kukolj","year":"2015","journal-title":"Biochim. Et Biophys. Acta (BBA)\u2014Mol. Cell Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/00004872-200018080-00011","article-title":"Urokinase Plasminogen Activator Enhances Neointima Growth and Reduces Lumen Size in Injured Carotid Arteries","volume":"18","author":"Plekhanova","year":"2000","journal-title":"J. Hypertens."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0021-9150(01)00511-1","article-title":"Urokinase Plasminogen Activator Augments Cell Proliferation and Neointima Formation in Injured Arteries via Proteolytic Mechanisms","volume":"159","author":"Plekhanova","year":"2001","journal-title":"Atherosclerosis"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1097\/01.ASN.0000064292.37793.FB","article-title":"Urokinase Receptor Deficiency Accelerates Renal Fibrosis in Obstructive Nephropathy","volume":"14","author":"Zhang","year":"2003","journal-title":"JASN"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0002-9440(10)64529-4","article-title":"The Development of Bleomycin-Induced Pulmonary Fibrosis in Mice Deficient for Components of the Fibrinolytic System","volume":"157","author":"Swaisgood","year":"2000","journal-title":"Am. J. Pathol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1164\/ajrccm.157.2.9707052","article-title":"Role of Urokinase in the Fibrogenic Response of the Lung to Mineral Particles","volume":"157","author":"Lardot","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000490355","article-title":"The Clinical Significance of Body Weight Loss in Idiopathic Pulmonary Fibrosis Patients","volume":"96","author":"Nakatsuka","year":"2018","journal-title":"Respiration"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1164\/rccm.202003-0736LE","article-title":"Clinical Course and Outcomes of 344 Intensive Care Patients with COVID-19","volume":"201","author":"Wang","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e0246030","DOI":"10.1371\/journal.pone.0246030","article-title":"Risk Factors for Mortality of Coronavirus Disease-2019 (COVID-19) Patients in Two Centers of Hubei Province, China: A Retrospective Analysis","volume":"16","author":"Zhang","year":"2021","journal-title":"PLoS ONE"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"360","DOI":"10.14336\/AD.2021.0805","article-title":"ACE2 and COVID-19 Susceptibility and Severity","volume":"13","author":"Zheng","year":"2022","journal-title":"Aging Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e001424","DOI":"10.1136\/openhrt-2020-001424","article-title":"Manipulation of ACE2 Expression in COVID-19","volume":"7","author":"Chaudhry","year":"2020","journal-title":"Open Heart"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijid.2021.11.028","article-title":"Circulating ACE2 Activity Predicts Mortality and Disease Severity in Hospitalized COVID-19 Patients","volume":"115","author":"Fagyas","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3390\/cells9020308","article-title":"UPAR Knockout Results in a Deep Glycolytic and OXPHOS Reprogramming in Melanoma and Colon Carcinoma Cell Lines","volume":"9","author":"Biagioni","year":"2020","journal-title":"Cells"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fonc.2019.00080","article-title":"Targeting UPAR by CRISPR\/Cas9 System Attenuates Cancer Malignancy and Multidrug Resistance","volume":"9","author":"Wang","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_71","unstructured":"Commissioner, O. (2022, July 10). FDA Approves First Treatment for Patients with Plasminogen Deficiency, a Rare Genetic Disorder, Available online: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-treatment-patients-plasminogen-deficiency-rare-genetic-disorder."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2796.1994.tb00824.x","article-title":"Transgenic Animals as Tools for the Study of Fibrinolysis In Vivo","volume":"236","author":"Carmeliet","year":"1994","journal-title":"J. Intern. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/RLI.0000000000000071","article-title":"Magnetic Resonance Imaging for Noninvasive Assessment of Lung Fibrosis Onset and Progression: Cross-Validation and Comparison of Different Magnetic Resonance Imaging Protocols with Micro-Computed Tomography and Histology in the Bleomycin-Induced Mouse Model","volume":"49","author":"Poelmans","year":"2014","journal-title":"Investig. Radiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and Regulation of Akt\/PKB by the Rictor-MTOR Complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1261\/rna.2192803","article-title":"Lentivirus-Delivered Stable Gene Silencing by RNAi in Primary Cells","volume":"9","author":"Stewart","year":"2003","journal-title":"RNA"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A New Mathematical Model for Relative Quantification in Real-Time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated Analysis of Multimodal Single-Cell Data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.21037\/jtd.2018.07.75","article-title":"Deletion of ACTA2 in Mice Promotes Angiotensin II Induced Pathogenesis of Thoracic Aortic Aneurysms and Dissections","volume":"10","author":"Cheng","year":"2018","journal-title":"J Thorac Dis"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.stemcr.2016.12.006","article-title":"Mesenchymal to Epithelial Transition Mediated by CDH1 Promotes Spontaneous Reprogramming of Male Germline Stem Cells to Pluripotency","volume":"8","author":"An","year":"2017","journal-title":"Stem Cell Rep."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/2\/1382\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:06:14Z","timestamp":1760119574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/2\/1382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":79,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["ijms24021382"],"URL":"https:\/\/doi.org\/10.3390\/ijms24021382","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]}}}